Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CVRX
CVRX, INC.
NASDAQ
$2.95
▼ DOWN 2.96% (-0.09)

KEY STATISTICS

Market Cap$78.28 M
52w High$11.30
52w Low$2.20
Dividend Yield—
Frequency—
P/E-1.46
Volume496.17K
Shares Out.26.54M

COMPANY

LEADERSHIP

Kevin Hykes
CHIEF EXECUTIVE
Kevin Hykes

COMPENSATION 2026

Salary$70,233
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$212,083
Total$9,082,769

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 30, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
223

PRICE TARGET

Target High$5.00
Target Low$3.50
Target Median$4.00
Target Consensus$4.13

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$13.94M
NOV
4
WED

PRICE

$2.95 ▼ DOWN 2.96% (−$0.09)
$3.00$3.089:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.95

About CVRx, Inc.

https://www.barostim.com ↗

CVRx, Inc. is a Minneapolis-based medical device company that develops and sells neuromodulation solutions like Barostim to improve symptoms in heart failure patients worldwide.

INDUSTRY

Medical - Devices

A PRODUCT CVRX, INC. IS KNOWN FOR

Barostim NEO2
Barostim NEO2

The Barostim NEO2 by CVRx is a smaller, longer-lasting implantable neuromodulation device that delivers electrical pulses to carotid baroreceptors to treat heart failure symptoms.

COMPETITORS

COMPETITOR
ABT COMPARE
BSX COMPARE
EW COMPARE
LIVN COMPARE
MDT COMPARE

Revenue by Products

IconPRODUCTQ2-2026
Reportable Segment$15.71M

Revenue by Geography

MapREGIONQ2-2025Q3-2025Q4-2025Q1-2026
UNITED STATES$12.24M $13.49M ▲$14.95M ▲$13.65M ▼
Other Countries$1.35M — — —
NonUS— $1.2M — $1.12M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
46
LISTED HERE
10
RANKED BY POSITION SIZE
VTS.AX
0.00% · 684.1K
IWM
0.00% · 366.8K
R2SC.L
0.00% · 28.8K
DFMC
0.00% · 13.2K
XRS2.F
0.00% · 11.5K
RSSL
0.00% · 7.3K
URTY
0.00% · 626
AVSC
0.00% · 358
EB
EBI
0.00% · 22
RTYS.L
0.00% · 0

INSTITUTIONAL OWNERSHIP

SHARES OWNED
66.83%
HOLDERS
135
TOP 12 OF 135 · RANKED BY POSITION SIZE
Johnson & Johnson
4.1M sh · $33.11M
Johnson & Johnson Innovation - Jjdc, Inc.
3.5M sh · $97.88M
Nea Management Company, LLC
2.0M sh · $19.17M
Blackrock, Inc.
1.2M sh · $6.4M
Royal Bank Of Canada
1.2M sh · $6.34M
Vanguard Group Inc
1.1M sh · $7.96M
Gsk Plc
1.0M sh · $9.53M
Silvercrest Asset Management Group LLC
878.1K sh · $4.51M
Blackrock Inc.
875.8K sh · $10.5M
Balyasny Asset Management L.P.
814.9K sh · $5.79M
Parkman Healthcare Partners LLC
491.4K sh · $3.97M
Geode Capital Management, LLC
440.8K sh · $2.27M

RATINGS SNAPSHOT

Overall rating: D+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

TRADES BY CONGRESS

SENATE TRADES
Richard Blumenthal
Richard Blumenthal
Sale
2026-07-08

INSIDER TRADES

★
OFFICER: CHIEF OPERATING OFFICER
Binkowski Brent
Sale · 1.3K shares
2026-08-12
★
OFFICER: CHIEF OPERATING OFFICER
Binkowski Brent
Purchase · 26.2K shares
2026-08-13
★
DIRECTOR
SHADAN MARTHA
Purchase · 11.2K shares
2026-06-01
★
DIRECTOR
Jain Mudit K.
Purchase · 8.7K shares
2026-06-01

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 1
HOLD 1
BUY 1
3 GRADES IN THE LAST 12 MONTHS
Cantor Fitzgerald OVERWEIGHT Lake Street HOLD Canaccord Genuity BUY

SECTORS PEERS

PEERPRICE
CERS$2.65COMPARE
SGHT$8.55COMPARE
MASS$10.73COMPARE
SENS$9.33COMPARE
VMD$8.82COMPARE
PRQR$2.29COMPARE
QTRX$2.64COMPARE
NNOX$0.83COMPARE